Step Therapy Fail-First Rules: Pharmacy Liens Bypass Them

James Wong, PharmD — Founder & CEO | March 29, 2026 | 6 min read

Step therapy requirements force personal injury patients to fail on cheaper medications before accessing prescribed treatments. Pharmacy liens through LienScripts bypass step therapy entirely, delivering the right medication from day one.

Step Therapy Fail-First Rules: Pharmacy Liens Bypass Them

Step therapy — also called fail-first — is an insurance cost-control policy that requires patients to try and fail on one or more lower-cost medications before the insurer will approve coverage for the medication the physician actually prescribed. For personal injury patients, step therapy is particularly damaging because it forces injured clients to endure weeks or months on medications their doctor considers suboptimal, creating treatment delays, unnecessary suffering, and a weaker medical record. Pharmacy liens through LienScripts bypass step therapy requirements completely because lien-based dispensing does not involve insurance approval.

• Step therapy forces personal injury patients to use cheaper medications before the insurer will cover the physician's preferred treatment
• Fail-first protocols can require 30-90 days on each step medication before the patient can advance to the prescribed drug
• Each failed step is a period of suboptimal treatment that worsens outcomes and creates a record of inadequate response
• Pharmacy liens through LienScripts dispense the physician's prescribed medication immediately with no step therapy requirements
• LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report documenting the clinical rationale for each medication, including why the specific drug was chosen over alternatives

What Step Therapy Means for Injured Patients

Step therapy protocols are designed by insurance pharmacy benefit managers (PBMs) to reduce drug spending by requiring patients to use the cheapest available option first. Only after the patient has documented a "failure" on that medication — meaning inadequate symptom relief or intolerable side effects — will the insurer consider covering the next-tier drug.

A typical step therapy sequence for neuropathic pain:

• Step 1: Gabapentin (generic, low cost) — must try for 30+ days
• Step 2: Pregabalin (Lyrica) — available only after documented gabapentin failure
• Step 3: Duloxetine or combination therapy — available only after step 2 failure

If the treating physician believes the patient needs pregabalin based on clinical assessment, the insurer overrides that judgment and requires the patient to first spend 30 or more days on gabapentin — a medication the physician did not prefer for this specific patient.

According to James Wong, PharmD, founder of LienScripts, "Step therapy is the insurance company telling your client's doctor that they know better. In personal injury cases, the treating physician has examined the patient, assessed the injury, and prescribed a specific medication for clinical reasons. Forcing the patient to fail on a cheaper drug first is not medicine — it is cost management."

[!KEY] Step therapy overrides the treating physician's clinical judgment by requiring patients to fail on medications the doctor did not choose. For personal injury patients, every day on the wrong medication is a day of suboptimal treatment, unnecessary pain, and weakened case documentation.

How Fail-First Damages Personal Injury Cases

The harm from step therapy goes beyond clinical outcomes. Fail-first protocols create specific legal vulnerabilities in personal injury cases.

Case damage from step therapy compliance:

• Extended pain and suffering — the patient endures weeks on ineffective medications, but the medical record may not clearly document the suffering during this period
• Weakened treatment narrative — the record shows the patient "tried" a cheaper medication first, which defense can spin as evidence that the condition was manageable with less aggressive treatment
• Delayed recovery — suboptimal medication delays healing, potentially extending the case timeline and increasing total medical costs
• Inconsistent medication record — switching between medications creates a complicated dispensing history that is harder to present clearly in a demand package

Defense exploitation of step therapy records:

Defense adjusters and attorneys are trained to use step therapy records against plaintiffs. Their arguments include:

• "The patient was treated with gabapentin — a generic medication — showing the condition did not require expensive treatment"
• "The patient tried multiple medications, suggesting the prescribing physician was uncertain about the diagnosis"
• "The frequent medication changes indicate the condition was not responding to treatment at all"

These arguments are disingenuous but effective. Pharmacy liens prevent them by ensuring the patient receives the correct medication from the start.

[!TIP] If your client is currently stuck in a step therapy protocol — taking a medication the physician considers suboptimal while waiting to qualify for the preferred drug — enroll them in LienScripts immediately. The physician can then prescribe the intended medication, and the patient can fill it without step therapy restrictions.

Medications Commonly Subject to Step Therapy

Pain management:

• Pregabalin (requires gabapentin failure first)
• Brand-name NSAIDs (require generic NSAID failure)
• Extended-release formulations (require immediate-release failure)

Mental health (injury-related PTSD, anxiety, depression):

• SNRIs like duloxetine (require SSRI failure first)
• Brand-name SSRIs (require generic SSRI failure)
• Buspirone for anxiety (may require SSRI failure first)

Muscle relaxants:

• Tizanidine or brand formulations (require cyclobenzaprine failure)
• Combination products (require single-agent failure)

Specialty medications:

• Nearly all specialty and biologic medications require multi-step protocols

How Pharmacy Liens Eliminate Step Therapy

Pharmacy liens through LienScripts operate outside the insurance benefit structure. No insurance claim is filed, so no step therapy protocol applies.

The process:

1. Treating physician prescribes the medication based on clinical judgment
2. Patient fills the prescription at a LienScripts network pharmacy
3. The medication is dispensed immediately — no step therapy, no prior auth, no formulary check
4. The cost is added to the pharmacy lien balance
5. The lien is satisfied from settlement proceeds

The physician's clinical judgment is honored without interference. The patient receives the right medication on day one.

As Amar Lunagaria, PharmD, LienScripts' Chief Pharmacist explains, "When a physician prescribes pregabalin for a patient with documented nerve damage from a car accident, there is a clinical reason they chose pregabalin over gabapentin. Maybe the patient has a history of gabapentin side effects. Maybe the injury pattern warrants a more targeted approach. The pharmacy lien lets the physician make that call without an insurance company second-guessing the decision."

Building the Stronger Treatment Record

Bypassing step therapy through a pharmacy lien creates a cleaner, more compelling treatment record.

Without step therapy (lien-based):

• Day 1: Physician prescribes pregabalin for neuropathic pain
• Day 1: Patient fills pregabalin at LienScripts network pharmacy
• Weeks 2-4: Patient reports symptom improvement
• The record shows: correct medication prescribed, immediate access, positive response

With step therapy (insurance-based):

• Day 1: Physician prescribes pregabalin, insurance denies
• Day 2: Physician prescribes gabapentin as step therapy requirement
• Weeks 2-6: Patient takes gabapentin with inadequate relief
• Week 7: Physician documents gabapentin failure, submits step therapy override
• Week 8-9: Insurance reviews and approves pregabalin
• Week 10: Patient finally fills pregabalin
• The record shows: medication switches, documented failures, 10 weeks of suboptimal treatment

The lien-based record is stronger in every respect — for the demand package, for the MERIT report, and for the client's recovery.

[!KEY] A pharmacy lien creates a clean treatment record that shows the physician prescribed the right medication and the patient received it immediately. Step therapy creates a muddled record of failed medications and delays that defense adjusters will use against your client.

Frequently Asked Questions

Can the insurer require step therapy for lien-based prescriptions?

No. Lien-based prescriptions are not billed to insurance. The insurer has no role in the transaction and cannot impose step therapy, prior authorization, or any other coverage requirements.

What if the patient already started step therapy?

The patient can transition to the LienScripts program at any point. The physician can then prescribe the originally intended medication, and the patient can begin filling it immediately through the lien.

Does bypassing step therapy affect the patient's insurance coverage?

No. The patient's insurance remains active for non-injury medications. Lien-based dispensing for injury-related prescriptions is a separate transaction that does not affect the patient's insurance benefits.

Will the step therapy record hurt the case?

If the patient was already in step therapy before enrolling in LienScripts, the record of insurance-imposed barriers and medication failures can actually support the demand narrative by documenting the obstacles the patient faced in accessing appropriate care.